HRP20090629T1 - Aminoacil-prolijek derivati i lijekovi za liječenje tromboemboličkih poremećaja - Google Patents

Aminoacil-prolijek derivati i lijekovi za liječenje tromboemboličkih poremećaja Download PDF

Info

Publication number
HRP20090629T1
HRP20090629T1 HR20090629T HRP20090629T HRP20090629T1 HR P20090629 T1 HRP20090629 T1 HR P20090629T1 HR 20090629 T HR20090629 T HR 20090629T HR P20090629 T HRP20090629 T HR P20090629T HR P20090629 T1 HRP20090629 T1 HR P20090629T1
Authority
HR
Croatia
Prior art keywords
formula
compound
image
group
hydrogen
Prior art date
Application number
HR20090629T
Other languages
English (en)
Croatian (hr)
Inventor
Lerchen Hans-Georg
Krenz Ursula
Schlemmer Karl-Heinz
Perzborn Elisabeth
Keldenich Joerg
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of HRP20090629T1 publication Critical patent/HRP20090629T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090629T 2006-02-16 2007-02-06 Aminoacil-prolijek derivati i lijekovi za liječenje tromboemboličkih poremećaja HRP20090629T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007146A DE102006007146A1 (de) 2006-02-16 2006-02-16 Aminoacyl-Prodrugs
PCT/EP2007/001135 WO2007093328A1 (de) 2006-02-16 2007-02-06 Aminoacyl-prodrug derivate und arzneimittel zur behandlung von thromboembolischen erkrankungen

Publications (1)

Publication Number Publication Date
HRP20090629T1 true HRP20090629T1 (hr) 2010-01-31

Family

ID=38179935

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090629T HRP20090629T1 (hr) 2006-02-16 2007-02-06 Aminoacil-prolijek derivati i lijekovi za liječenje tromboemboličkih poremećaja

Country Status (22)

Country Link
US (2) US8101601B2 (pt)
EP (1) EP1987026B1 (pt)
JP (1) JP5225864B2 (pt)
KR (1) KR20080094696A (pt)
CN (1) CN101384585B (pt)
AT (1) ATE440839T1 (pt)
AU (1) AU2007214766B2 (pt)
BR (1) BRPI0708064A2 (pt)
CA (1) CA2642376C (pt)
CY (1) CY1109375T1 (pt)
DE (2) DE102006007146A1 (pt)
DK (1) DK1987026T3 (pt)
ES (1) ES2330689T3 (pt)
HR (1) HRP20090629T1 (pt)
IL (1) IL192987A0 (pt)
PL (1) PL1987026T3 (pt)
PT (1) PT1987026E (pt)
RS (1) RS51190B (pt)
RU (1) RU2435768C2 (pt)
SI (1) SI1987026T1 (pt)
WO (1) WO2007093328A1 (pt)
ZA (1) ZA200806891B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II
DE102007032345A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
DE102007032347A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
CN101875655B (zh) * 2009-04-28 2012-05-09 天津药物研究院 氨基苯甲酸衍生物及其制备方法和用途
US8971019B2 (en) 2012-03-16 2015-03-03 Avx Corporation Wet capacitor cathode containing an alkyl-substituted poly(3,4-ethylenedioxythiophene)
CN102746287B (zh) * 2012-06-21 2014-05-28 成都苑东药业有限公司 一种恶唑烷酮化合物及其制备方法
WO2014102822A2 (en) 2012-12-26 2014-07-03 Wanbury Ltd. Aldehyde derivative of substitute oxazolidinones
PT2895176T (pt) 2012-12-26 2017-01-27 Wanbury Ltd Intermediário de rivaroxabano e a sua preparação
CN114384185A (zh) * 2022-01-20 2022-04-22 北京航空航天大学 用于检测γ-氨基丁酸含量的试剂在制备诊断静脉流出障碍性疾病的试剂盒中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1196414T3 (da) * 1999-06-25 2003-11-24 Vertex Pharma Prolægemiddel af carbamathæmmer for IMPDH
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7049443B2 (en) 2001-07-12 2006-05-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
DE102004062475A1 (de) 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
DE102005047558A1 (de) 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II

Also Published As

Publication number Publication date
IL192987A0 (en) 2009-02-11
DE502007001402D1 (de) 2009-10-08
HK1130252A1 (en) 2009-12-24
WO2007093328A1 (de) 2007-08-23
EP1987026B1 (de) 2009-08-26
PT1987026E (pt) 2009-10-30
ATE440839T1 (de) 2009-09-15
CA2642376C (en) 2014-08-12
KR20080094696A (ko) 2008-10-23
PL1987026T3 (pl) 2010-03-31
JP2009526788A (ja) 2009-07-23
CA2642376A1 (en) 2007-08-23
RS51190B (sr) 2010-10-31
AU2007214766A1 (en) 2007-08-23
SI1987026T1 (sl) 2010-01-29
CN101384585A (zh) 2009-03-11
US20120088761A1 (en) 2012-04-12
DE102006007146A1 (de) 2007-08-23
BRPI0708064A2 (pt) 2011-05-17
US8334284B2 (en) 2012-12-18
CY1109375T1 (el) 2014-07-02
ZA200806891B (en) 2010-02-24
ES2330689T3 (es) 2009-12-14
RU2008136769A (ru) 2010-03-27
AU2007214766B2 (en) 2013-05-02
RU2435768C2 (ru) 2011-12-10
DK1987026T3 (da) 2009-11-02
JP5225864B2 (ja) 2013-07-03
US20110034453A1 (en) 2011-02-10
US8101601B2 (en) 2012-01-24
CN101384585B (zh) 2012-09-26
EP1987026A1 (de) 2008-11-05

Similar Documents

Publication Publication Date Title
DE3884563T2 (de) Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel.
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
LU90317I2 (fr) Tacrolimus et ses sels et dérivés pharmaceutiquement acceptables
HRP20110445T1 (hr) Spojevi bisadenozina kao agonisti receptora adenozina a2a
AR013085A1 (es) Compuestos derivados de macrolidos c-4'' sustituidos, composicion farmaceutica, metodo de preparacion, compuestos intermediarios para su preparacion
CA2479103A1 (en) 1-azabicyclic n-biarylamides with affinity for the alpha7 nicotinic acetylcholine receptor
CA2642376A1 (en) Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
ATE14423T1 (de) Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.
MX340965B (es) Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular.
AR035479A1 (es) Derivados de eteres biarilicos y sus sales, composiciones farmaceuticas que los comprenden y procedimientos para el tratamiento de trastornos o afecciones
EA036525B1 (ru) Конденсированное трициклическое производное -аминокислоты, способ его получения и его медицинское применение
JP2008526999A5 (pt)
DE10226921A1 (de) Antibakterielle Amid-Makrozyklen
AR015994A1 (es) Derivados de cetolidos 2-halo-6-o-sustituidos, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procesos parasu preparacion
DK0641793T3 (da) 5-amino-8-methyl-7-pyrrolidinylquinolin-3-carboxylsyrederivat
US5221692A (en) Ether linked and relatively nonpungent analogues of N-nonanoyl vanillylamide
RU2009110246A (ru) Аминоацильные производные в качестве пролекарств и лекарственные средства для лечения тромбоэмболических заболеваний
RU2010104475A (ru) Аминоацильные пролекарства в качестве фармацевтически действующих веществ для лечения тромбоэмболических заболеваний
AR043186A1 (es) Indozolamidas dotadas de actividad analgesica, metodo de preparacion de las mismas y compuesto farmaceutico que las comprende
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
AU2009212519A1 (en) 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
IL291981A (en) Quinolone carboxylic acid derivatives
OA07716A (fr) Dérivés d'acides isoindoledicarboxyliques, leur préparation et compositions pharmaceutiques les contenant.
NZ793327B2 (en) Tetrazole derivatives as trpa1 inhibitors